Feizpour et al. assess the utility of a high-performing Alzheimer’s disease (AD) blood test to discriminate AD disease stages. The blood test reliably detects Intermediate and Advanced stages of disease, and while the test is less effective at distinguishing Advanced stage alone, it may reduce reliance on expensive brain scans.
- Azadeh Feizpour
- Vincent Doré
- Christopher C. Rowe
